Bonus BioGroup Ltd. (BONS.TA)
ILA 9.1
(0.0%)
ILA 9.1
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 15.58 Million ILS | -14.47% |
| 2022 | 18.22 Million ILS | -8.4% |
| 2021 | 19.89 Million ILS | -4.15% |
| 2020 | 20.75 Million ILS | 0.2% |
| 2019 | 20.71 Million ILS | 55.31% |
| 2018 | 13.33 Million ILS | 11.49% |
| 2017 | 11.96 Million ILS | 16.59% |
| 2016 | 10.25 Million ILS | 43.58% |
| 2015 | 7.14 Million ILS | 82.32% |
| 2014 | 3.91 Million ILS | 128.91% |
| 2013 | 1.71 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 16.87 Million ILS | 8.28% |
| 2024 Q2 | 16.62 Million ILS | -1.5% |
| 2023 FY | 15.58 Million ILS | -14.47% |
| 2023 Q1 | 17.26 Million ILS | -5.27% |
| 2023 Q2 | 15.91 Million ILS | -7.78% |
| 2023 Q3 | 15.44 Million ILS | -3.0% |
| 2023 Q4 | 15.58 Million ILS | 0.93% |
| 2022 Q2 | 18.37 Million ILS | -1.98% |
| 2022 FY | 18.22 Million ILS | -8.4% |
| 2022 Q3 | 16.6 Million ILS | -9.63% |
| 2022 Q1 | 18.74 Million ILS | -5.78% |
| 2022 Q4 | 18.22 Million ILS | 9.76% |
| 2021 FY | 19.89 Million ILS | -4.15% |
| 2021 Q4 | 19.89 Million ILS | 0.97% |
| 2021 Q1 | 17.51 Million ILS | -15.59% |
| 2021 Q2 | 5.38 Million ILS | -69.26% |
| 2021 Q3 | 19.7 Million ILS | 265.83% |
| 2020 Q1 | 22.78 Million ILS | 10.03% |
| 2020 Q2 | 23.05 Million ILS | 1.16% |
| 2020 Q3 | 23.52 Million ILS | 2.03% |
| 2020 Q4 | 20.75 Million ILS | -11.77% |
| 2020 FY | 20.75 Million ILS | 0.2% |
| 2019 Q2 | 18.99 Million ILS | 1.42% |
| 2019 Q3 | 19.96 Million ILS | 5.06% |
| 2019 Q1 | 18.73 Million ILS | 40.47% |
| 2019 FY | 20.71 Million ILS | 55.31% |
| 2019 Q4 | 20.71 Million ILS | 3.76% |
| 2018 Q3 | 12.55 Million ILS | -8.91% |
| 2018 FY | 13.33 Million ILS | 11.49% |
| 2018 Q2 | 13.78 Million ILS | 7.44% |
| 2018 Q1 | 12.82 Million ILS | 7.24% |
| 2018 Q4 | 13.33 Million ILS | 6.23% |
| 2017 Q4 | 11.96 Million ILS | 8.59% |
| 2017 FY | 11.96 Million ILS | 16.59% |
| 2017 Q1 | 11.23 Million ILS | 9.53% |
| 2017 Q2 | 10.87 Million ILS | -3.22% |
| 2017 Q3 | 11.01 Million ILS | 1.29% |
| 2016 Q4 | 10.25 Million ILS | 0.91% |
| 2016 FY | 10.25 Million ILS | 43.58% |
| 2016 Q2 | 8.98 Million ILS | 8.41% |
| 2016 Q1 | 8.28 Million ILS | 16.01% |
| 2016 Q3 | 10.16 Million ILS | 13.13% |
| 2015 Q2 | 5.03 Million ILS | 21.79% |
| 2015 Q3 | 6.52 Million ILS | 29.76% |
| 2015 Q4 | 7.14 Million ILS | 9.47% |
| 2015 Q1 | 4.13 Million ILS | 5.38% |
| 2015 FY | 7.14 Million ILS | 82.32% |
| 2014 Q1 | 1.33 Million ILS | -22.25% |
| 2014 Q4 | 3.91 Million ILS | 64.87% |
| 2014 FY | 3.91 Million ILS | 128.91% |
| 2014 Q3 | 2.37 Million ILS | 14.39% |
| 2014 Q2 | 2.07 Million ILS | 56.12% |
| 2013 FY | 1.71 Million ILS | 0.0% |
| 2013 Q1 | 1.51 Million ILS | 0.0% |
| 2013 Q2 | 1.7 Million ILS | 12.66% |
| 2013 Q3 | 1.61 Million ILS | -5.56% |
| 2013 Q4 | 1.71 Million ILS | 6.07% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Matricelf Ltd | 3.7 Million ILA | -321.189% |